Sant'Angelo de Lomnardi, Italy Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2007
NCT00710788
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Nephrology Division, ASL AV1, Sant'Angelo de Lomnardi, Italy

Active Ingredients

Drugs in Other Trials (2)

calcium carbonate (1 trial)

sevelamer (renagel) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2